Regenxbio Inc (RGNX)

Financial leverage ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total assets	US$ in thousands	573,970	833,268	1,113,900	708,164	497,908
Total stockholders’ equity	US$ in thousands	311,742	516,195	764,298	377,753	450,197
Financial leverage ratio		1.84	1.61	1.46	1.87	1.11

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $573,970K ÷ $311,742K
= 1.84

The financial leverage ratio of Regenxbio Inc has shown some fluctuation over the past five years. The ratio stood at 1.84 in 2023, indicating that the company utilized a higher level of debt to finance its operations compared to the equity. This represents an increase from the previous year when the ratio was 1.61.

In 2022, the financial leverage ratio was lower at 1.61, suggesting that the company relied less on debt to fund its activities relative to equity. The ratio had increased from 1.46 in 2021, which indicates a shift towards higher leverage in 2022.

The ratio spiked to 1.87 in 2020, signifying a relatively high level of debt financing compared to equity for that year. Prior to that, in 2019, the financial leverage ratio was notably lower at 1.11, indicating a lower reliance on debt to support operations, with a higher proportion funded by equity.

Overall, the trend in the financial leverage ratio for Regenxbio Inc shows variability in the company's capital structure mix over the past five years, with periods of higher and lower leverage, which could reflect strategic decisions related to funding and growth strategies. It is important to assess the financial leverage ratio in conjunction with other financial metrics to gain a comprehensive understanding of the company's financial health and risk profile.